115 results
Page 2 of 6
424B5
661tnhk
12 Dec 22
Prospectus supplement for primary offering
7:12am
8-K
EX-99.1
hh6md
12 Dec 22
Entry into a Material Definitive Agreement
6:49am
8-K
EX-10.4
lpu 6gkj1bqejjvvxi
12 Dec 22
Entry into a Material Definitive Agreement
6:49am
8-K
EX-99.1
l6d3sie u2g
16 Nov 22
Regulation FD Disclosure
9:24am
8-K
EX-99.1
zcsdl
9 Nov 22
Societal CDMO Reports Third Quarter 2022 Financial Results
4:13pm
8-K
EX-99.1
adw9p6s0qn030
10 Aug 22
Societal CDMO Reports Second Quarter 2022 Financial Results
4:13pm
8-K
EX-99.1
onttnbpytqjbfu3zi
8 Jun 22
Corporate Presentation May 2022
7:35am
SC TO-I
EX-99
o2o4t
1 Jun 22
Issuer tender offer statement
5:05pm
8-K
EX-99.1
3ht2pl
11 May 22
Societal CDMO Reports First Quarter 2022 Financial Results
4:09pm
8-K
EX-99.2
afdoa
11 May 22
Societal CDMO Reports First Quarter 2022 Financial Results
4:09pm
8-K
EX-99.1
xqvv8v vhr4w5ghfv
5 May 22
Societal Cdmo Signs Three-year Manufacturing and Supply Agreement with Infectopharm for Ritalin La® In Europe
7:05am
8-K
EX-99.1
1910aadw 4xohu
21 Mar 22
Recro Announces Name Change to Societal Cdmo to Reflect Corporate Expansion and Transformation
8:00am
8-K
EX-99.2
r8te764o2j
1 Mar 22
Recro Reports Fourth Quarter and Year End 2021 Financial Results
4:12pm
8-K
EX-99.1
si88 y7blj8u055bmk2n
1 Mar 22
Recro Reports Fourth Quarter and Year End 2021 Financial Results
4:12pm